Merz’s Xeomin meets in Phase III trial for PD-associated sialorrhea
The Merz Neurosciences unit of Merz GmbH & Co. KGaA (Frankfurt, Germany) reported top-line data from the Phase III SIAXI trial to treat sialorrhea
Gathering data...
The Merz Neurosciences unit of Merz GmbH & Co. KGaA (Frankfurt, Germany) reported top-line data from the Phase III SIAXI trial to treat sialorrhea